Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.

TitleLoss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.
Publication TypeJournal Article
Year of Publication2016
AuthorsMadeo, M, Stewart, M, Sun, Y, Sahir, N, Wiethoff, S, Chandrasekar, I, Yarrow, A, Rosenfeld, JA, Yang, Y, Cordeiro, D, McCormick, EM, Muraresku, CC, Jepperson, TN, McBeth, LJ, Seidahmed, MZain, Khashab, HYEl, Hamad, M, Azzedine, H, Clark, K, Corrochano, S, Wells, S, Elting, MW, Weiss, MM, Burn, S, Myers, A, Landsverk, M, Crotwell, PL, Waisfisz, Q, Wolf, NI, Nolan, PM, Padilla-Lopez, S, Houlden, H, Lifton, R, Mane, S, Singh, BB, Falk, MJ, Mercimek-Mahmutoglu, S, Bilguvar, K, Salih, MA, Acevedo-Arozena, A, Kruer, MC
JournalAm J Hum Genet
Volume98
Issue6
Pagination1249-1255
Date Published2016 06 02
ISSN1537-6605
Keywordsalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid, Brain Diseases, Electrophysiology, Epilepsy, Female, Humans, Hyperkinesis, Infant, Male, Membrane Proteins, Mutation, Nerve Tissue Proteins, Pedigree, Synaptic Transmission
Abstract

Glutamatergic neurotransmission governs excitatory signaling in the mammalian brain, and abnormalities of glutamate signaling have been shown to contribute to both epilepsy and hyperkinetic movement disorders. The etiology of many severe childhood movement disorders and epilepsies remains uncharacterized. We describe a neurological disorder with epilepsy and prominent choreoathetosis caused by biallelic pathogenic variants in FRRS1L, which encodes an AMPA receptor outer-core protein. Loss of FRRS1L function attenuates AMPA-mediated currents, implicating chronic abnormalities of glutamatergic neurotransmission in this monogenic neurological disease of childhood.

DOI10.1016/j.ajhg.2016.04.008
Alternate JournalAm. J. Hum. Genet.
PubMed ID27236917
PubMed Central IDPMC4908178
Grant ListUM1 HG006504 / HG / NHGRI NIH HHS / United States
R01 DE017102 / DE / NIDCR NIH HHS / United States
MC_UP_A390_1106 / / Medical Research Council / United Kingdom
G1001253 / / Medical Research Council / United Kingdom
G108/638 / / Medical Research Council / United Kingdom
MC_U142684173 / / Medical Research Council / United Kingdom
U54 HG006504 / HG / NHGRI NIH HHS / United States
U42 OD011174 / OD / NIH HHS / United States
R21 DE024300 / DE / NIDCR NIH HHS / United States
K08 NS083739 / NS / NINDS NIH HHS / United States
MR/J004758/1 / / Medical Research Council / United Kingdom
G0802760 / / Medical Research Council / United Kingdom
U54 HG006348 / HG / NHGRI NIH HHS / United States
2014112 / / Doris Duke Charitable Foundation / United States